Lantheus Holdings, Inc (LNTH)
Health Care ยท In Vitro & in Vivo Diagnostic Substances
Lantheus Holdings, Inc (LNTH) is listed on Nasdaq, where its shares have traded since June 25, 2015. SentiSense covers Lantheus Holdings, Inc in the Health Care sector, and its Standard Industrial Classification is In Vitro & in Vivo Diagnostic Substances. Mary Anne Heino is its chief executive officer. The company reports 1,193 employees, and its corporate website is www.lantheus.com.
About Lantheus Holdings, Inc
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.
Latest reported results
Lantheus Holdings, Inc. reported revenue of $389.9 million for Q3 FY2026, up 1.5% from the same period a year earlier.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 456 institutions reported holding LNTH, with 75.1 million shares worth $8.3 billion in aggregate. The largest reported holders were BlackRock, Vanguard and Farallon Capital Management.
More on LNTH
- LNTH sentiment: whether news and social coverage of Lantheus Holdings, Inc leans bullish or bearish, and the stories driving it.
- LNTH ownership: all 456 reporting institutions, plus insider and congressional trades.
- LNTH financials: revenue, net income, operating margin and free cash flow through Q3 FY2026.
Frequently asked questions
What does Lantheus Holdings, Inc do?
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes.
What sector is LNTH in?
SentiSense classifies Lantheus Holdings, Inc in the Health Care sector, and its Standard Industrial Classification is In Vitro & in Vivo Diagnostic Substances.
Where does LNTH stock trade?
Lantheus Holdings, Inc (LNTH) is listed on Nasdaq, where its shares have traded since June 25, 2015.
Who is the CEO of Lantheus Holdings, Inc?
Mary Anne Heino is the chief executive officer of Lantheus Holdings, Inc.